Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
UBS Group AG MCS Marcus Corp 13G 5.28% 2y
JPMORGAN CHASE & CO NGL NGL Energy Partners LP 13G 6.4% 2y
Trium Capital LLP AAIC Arlington Asset Investment Corp. 13G 0% 2y
Denis Phares DFLI Dragonfly Energy Holdings Corp. 13D/A 27.6% 2y
HURT CLINT PNRG Primeenergy Resources Corp 13D/A 8.58% 2y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D/A 13.7% 2y
John K. Scott, Jr. NAVB Navidea Biopharmaceuticals Inc. 13D/A 61.8% 2y
ORBIMED ADVISORS LLC CALC CalciMedica, Inc. 13D/A 2.9% 2y
Robert F. Taglich AIRI Air Industries Group 13D/A 14.53% 2y
Michael Taglich AIRI Air Industries Group 13D/A 21.01% 2y
Point72 Asset Management, L.P. SGMT Sagimet Biosciences Inc. 13G 5.3% 2y
Saba Capital Management, L.P. BSTZ BlackRock Science & Technology Term Trust 13D 5.13% 2y
IWH Sponsor LP WELNF Integrated Wellness Acquisition Corp 13G/A 12.1% 2y
Dapice Joshua J. CZOO Cazoo Group Ltd 13D/A 14.6% 2y
Longitude Capital Partners IV, LLC VERA Vera Therapeutics, Inc. 13D/A 9.8% 2y
THOMPSON DAVIS & CO., INC. SMID Smith Midland Corp 13D/A 27.37% 2y
Qifeng Sun NA Nano Labs Ltd 13D/A 20.5% 2y
PERCEPTIVE ADVISORS LLC ATXS Astria Therapeutics, Inc. Common Stock 13D/A 11.9% 2y
clirSPV LLC CLIR ClearSign Technologies Corp 13D/A 16.8% 2y
Jianping Kong NA Nano Labs Ltd 13D/A 33.6% 2y
HORIZON KINETICS ASSET MANAGEMENT LLC TPL Texas Pacific Land Corp 13D/A 16.77% 2y
Apollo Management Holdings GP, LLC SNX Td Synnex Corp 13D/A 19.8% 2y
Conversant Capital LLC UHG United Homes Group, Inc. 13D 9.9% 2y
ORBIMED ADVISORS LLC AVBP ArriVent BioPharma, Inc. 13D 9.1% 2y
SPRING CREEK CAPITAL LLC PLAO Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares 13G 5.95% 2y
Longitude Capital Partners IV, LLC CGON CG Oncology, Inc. 13G 7% 2y
Cormorant Global Healthcare Master Fund, LP CRBP Corbus Pharmaceuticals Holdings, Inc. 13G 14.27% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC COGT Cogent Biosciences, Inc. 13G 6.4% 2y
Soleus Capital Master Fund, L.P. CCCC C4 Therapeutics, Inc. 13G 5.2% 2y
Ridgemont Equity Management III, LLC FWRD Forward Air Corp 13D 6.8% 2y
Harraden Circle Investments, LLC PBM Psyence Biomedical Ltd. 13G 9.71% 2y
Psyence Group Inc. PBM Psyence Biomedical Ltd. 13D 37.34% 2y
RA CAPITAL MANAGEMENT, L.P. ACET Adicet Bio, Inc. 13G 9.99% 2y
TANG CAPITAL MANAGEMENT, LLC DTIL Precision Biosciences Inc 13G 5.2% 2y
TANG CAPITAL MANAGEMENT, LLC LENZ LENZ Therapeutics, Inc. 13G 5.4% 2y
ADAGE CAPITAL PARTNERS GP, L.L.C. MREO Mereo BioPharma Group plc 13G 7.17% 2y
Sumitomo Mitsui Trust Group, Inc. CDNA CareDx, Inc. 13G 5.31% 2y
Owl Creek Asset Management, L.P. KACLF Kairous Acquisition Corp. Ltd 13G/A 0% 2y
Mawer Investment Management Ltd. OGN Organon & Co. 13G/A 0% 2y
GIC Private Ltd TWKS Thoughtworks Holding, Inc. Common Stock 13G/A 4.59% 2y
Owl Creek Asset Management, L.P. CSTAF Constellation Acquisition Corp I 13G 0% 2y
Hudson Bay Capital Management LP IGTA Inception Growth Acquisition Ltd 13G 6.67% 2y
DONALD SMITH & CO., INC. TPC Tutor Perini Corp 13G 7.5% 2y
Sumitomo Mitsui Trust Group, Inc. PACB Pacific Biosciences Of California, Inc. 13G/A 4.93% 2y
Owl Creek Asset Management, L.P. CAUD Collective Audience, Inc.. Common Stock 13G/A 0% 2y
Sumitomo Mitsui Trust Group, Inc. ROKU Roku, Inc 13G/A 4.7% 2y
Golden Navigate Investments Ltd BTDR Bitdeer Technologies Group 13G/A 14.6% 2y
Mawer Investment Management Ltd. NOA North American Construction Group Ltd. 13G/A 9.9% 2y
Millennium Management LLC FLYX Flyexclusive Inc. 13G/A 0.2% 2y
DONALD SMITH & CO., INC. BZH Beazer Homes USA Inc 13G 8.26% 2y